Dr Agarwals Eye Hospital Ltd.
BSE: 526783 | Sector: Health care |
NSE: N.A. | ISIN Code: INE934C01018 |
BSE 14:56 | 27 Jun | 624.00 |
-3.15 (-0.50%) |
OPEN
627.15 |
HIGH
627.15 |
LOW
601.65 |
NSE 05:30 | 01 Jan | Dr Agarwals Eye Hospital Ltd |
OPEN | 627.15 |
PREVIOUS CLOSE | 627.15 |
VOLUME | 204 |
52-Week high | 925.00 |
52-Week low | 380.70 |
P/E | 12.17 |
Mkt Cap.(Rs cr) | 293 |
Buy Price | 612.00 |
Buy Qty | 1.00 |
Sell Price | 620.00 |
Sell Qty | 1000.00 |
Dr Agarwals Eye Hospital Ltd. (DRAGARWALSEYE) - Net Sales
Market Cap
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
Aurobindo Pharma | 522.85 | -3.55 | -0.67 | 15823.68 |
Cipla | 936.10 | 2.70 | 0.29 | 13900.58 |
Dr Reddy's Labs | 4337.85 | 29.10 | 0.68 | 13349.10 |
Sun Pharma.Inds. | 840.15 | 16.05 | 1.95 | 12803.21 |
Lupin | 629.95 | 0.00 | 0.00 | 11055.93 |
Apollo Hospitals | 3799.70 | -35.90 | -0.94 | 9153.00 |
Zydus Lifesci. | 356.00 | 2.30 | 0.65 | 7790.40 |
Glenmark Pharma. | 387.65 | 3.90 | 1.02 | 7567.93 |
Alkem Lab | 3030.50 | 26.65 | 0.89 | 7219.68 |
Divi's Lab. | 3677.25 | -3.15 | -0.09 | 6798.61 |
Torrent Pharma. | 2866.25 | -9.25 | -0.32 | 6450.83 |
Ipca Labs. | 910.95 | 22.00 | 2.47 | 5114.11 |
Alembic Pharma | 748.55 | 22.45 | 3.09 | 5051.44 |
Laurus Labs | 468.70 | 2.10 | 0.45 | 4707.04 |
Abbott India | 18045.00 | -43.00 | -0.24 | 4310.02 |
Gland Pharma | 2678.95 | 35.25 | 1.33 | 3462.88 |
Glaxosmi. Pharma | 1500.00 | 0.25 | 0.02 | 3193.74 |
Granules India | 269.40 | 12.75 | 4.97 | 3134.98 |
Sanofi India | 6434.40 | 24.40 | 0.38 | 2956.60 |
Ajanta Pharma | 1259.40 | 9.55 | 0.76 | 2718.59 |
Quick Links for Dr Agarwals Eye Hospital:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices